{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:09:40Z","timestamp":1769918980321,"version":"3.49.0"},"reference-count":34,"publisher":"Baishideng Publishing Group Inc.","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.1836","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T04:10:47Z","timestamp":1241064647000},"page":"1836","source":"Crossref","is-referenced-by-count":21,"title":["Clinical usefulness of<sup>18<\/sup>F-FDG PET\/CT in the restaging of esophageal cancer after surgical resection and radiotherapy"],"prefix":"10.3748","volume":"15","author":[{"given":"Long","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Song","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-Ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-2252.","DOI":"10.1056\/NEJMra035010"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, Jager PL, Van Eck-Smit BL, Plukker JT, van Lanschot JJ. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review. Radiology 2005;236:841-851.","DOI":"10.1148\/radiol.2363041042"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kim TJ, Lee KH, Kim YH, Sung SW, Jheon S, Cho SK, Lee KW. Postoperative imaging of esophageal cancer: what chest radiologists need to know. Radiographics 2007;27:409-429.","DOI":"10.1148\/rg.272065034"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol 2005;60:547-554.","DOI":"10.1016\/j.crad.2004.09.002"},{"key":"ref6","unstructured":"Antoch G, Kanja J, Bauer S, Kuehl H, Renzing-Koehler K, Schuette J, Bockisch A, Debatin JF, Freudenberg LS. Comparison of PET, CT, and dual-modality PET\/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 2004;45:357-365."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-3210.","DOI":"10.1200\/JCO.2000.18.18.3202"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006;243:472-478.","DOI":"10.1097\/01.sla.0000208430.07050.61"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:1152-1160; discussion 1152-1160.","DOI":"10.1016\/j.athoracsur.2004.04.046"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426-1433.","DOI":"10.1046\/j.1365-2168.2000.01541.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Osugi H, Takemura M, Higashino M, Takada N, Lee S, Ueno M, Tanaka Y, Fukuhara K, Hashimoto Y, Fujiwara Y. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 2003;10:81-87.","DOI":"10.3892\/or.10.1.81"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205-211.","DOI":"10.1016\/j.jamcollsurg.2003.10.005"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Chen G, Wang Z, Liu XY, Liu FY. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 2007;31:1107-1114.","DOI":"10.1007\/s00268-006-0551-1"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-1944.","DOI":"10.1056\/NEJMoa032646"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S. Diagnostic and prognostic value of 18F-FDG PET\/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. J Nucl Med 2007;48:1251-1258.","DOI":"10.2967\/jnumed.106.036509"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480-508.","DOI":"10.2967\/jnumed.107.047787"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007;11:iii-iv, xi-267.","DOI":"10.3310\/hta11440"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000;120:1085-1092.","DOI":"10.1067\/mtc.2000.110464"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, Ogino T, Yoshida S. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 2005;35:316-323.","DOI":"10.1093\/jjco\/hyi095"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. Clinical role of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol 2008;14:4627-4632.","DOI":"10.3748\/wjg.14.4627"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Motoyama S, Saito R, Okuyama M, Maruyama K, Nanjo H, Ogawa J. Long-term survival after salvage resection of recurrent esophageal cancer with anterior mediastinal lymph node involvement: report of a case. Surg Today 2006;36:827-830.","DOI":"10.1007\/s00595-006-3242-5"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Shigemitsu K, Naomoto Y, Shirakawa Y, Haisa M, Gunduz M, Tanaka N. A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy. Jpn J Clin Oncol 2002;32:310-314.","DOI":"10.1093\/jjco\/hyf067"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Chen G, Wang Z, Liu XY, Zhang MY, Liu FY. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Eur J Cardiothorac Surg 2009;35:1-7.","DOI":"10.1016\/j.ejcts.2008.09.002"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002;41:118-123.","DOI":"10.1080\/028418602753669472"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Shioyama Y, Nakamura K, Ohga S, Nomoto S, Sasaki T, Yamaguchi T, Toba T, Yoshitake T, Terashima H, Honda H. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol 2007;37:918-923.","DOI":"10.1093\/jjco\/hym138"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Raoul JL, Le Pris&eacute; E, Meunier B, Julienne V, Etienne PL, Gosselin M, Launois B. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995;37:174-176.","DOI":"10.1136\/gut.37.2.174"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Tachibana M, Yoshimura H, Kinugasa S, Shibakita M, Dhar DK, Ueda S, Fujii T, Nagasue N. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 2003;29:580-587.","DOI":"10.1016\/S0748-7983(03)00111-2"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kuehl H, Antoch G, Stergar H, Veit-Haibach P, Rosenbaum-Krumme S, Vogt F, Frilling A, Barkhausen J, Bockisch A. Comparison of FDG-PET, PET\/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 2008;67:362-371.","DOI":"10.1016\/j.ejrad.2007.11.017"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Travaini LL, Trifir&ograve; G, Ravasi L, Monfardini L, Della Vigna P, Bonomo G, Chiappa A, Mallia A, Ferrari M, Orsi F. Role of [18F]FDG-PET\/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging 2008;35:1316-1322.","DOI":"10.1007\/s00259-008-0748-7"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Kuwano H. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 2004;91:1004-1009.","DOI":"10.1002\/bjs.4595"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000;232:743-752.","DOI":"10.1097\/00000658-200012000-00003"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Br&uuml;cher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmerman F, Siewert JR, Schwaiger M. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001;233:300-309.","DOI":"10.1097\/00000658-200103000-00002"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004;101:1776-1785.","DOI":"10.1002\/cncr.20585"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Roedl JB, Halpern EF, Colen RR, Sahani DV, Fischman AJ, Blake MA. Metabolic tumor width parameters as determined on PET\/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol 2009;11:54-60.","DOI":"10.1007\/s11307-008-0169-9"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i15\/1836.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T15:18:00Z","timestamp":1558279080000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i15\/1836.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.1836","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}